Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Personalized and Scalable Cognitive Remediation Approaches

11 września 2020 zaktualizowane przez: Alice Medalia, New York State Psychiatric Institute
The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.

Przegląd badań

Status

Zakończony

Szczegółowy opis

There are three phases of this study.

Phase 1: Development and Adaptation. The goal of this phase is to adapt currently used computer based CR approaches to make them more personalized and scalable. We will create two CR interventions which differ in choice and pacing of the cognitive exercises. This phase is complete.

Phase 2: Open Trial and Intervention Refinement. The goal of this phase is to obtain quantitative and qualitative feedback on the acceptability and usability of the interventions from participants to inform further refinement of the assessment and treatment packages. We will recruit ten subjects from an outpatient psychiatric rehabilitation program in New York City. After determining study eligibility, individuals will complete a standardized neuropsychological battery for schizophrenia assessment, and a 5-minute Tone Matching Test to assess basic auditory processing. Participants will be randomly assigned to receive one of two intervention packages, developed in Phase 1. Each session includes 60 minutes of computer-based learning activities and a 15 minute therapist-led discussion that links the computer activities to cognition as applied to daily tasks and recovery goals. Participants will complete a total of 10 sessions attending 2-3 times weekly for 5 weeks. During each session, participants will be asked to keep a log of software used. At the conclusion of this abbreviated trial, the participants will participate in focus groups in which they will be asked to provide verbal feedback on how enjoyable, engaging, and useful they perceived the computer and discussion based exercises to be. Participants will be asked to provide verbal feedback on the assessment procedures. CR clinicians will join the research team to discuss participants' engagement and their experience with administering the Tone Matching Test and interventions. Qualitative data summarized from participant logs and focus groups will be considered by the research team to refine the assessment battery, treatment parameters, and rubric of learning exercises. This phase is complete.

Phase 3: Pilot Feasibility Trial. People with a diagnosis of schizophrenia or schizoaffective disorder may be referred by their treating clinician or may respond to posted advertisements to inquire about study participation. After being informed of study procedures, interested individuals will be asked to sign a consent form that documents willingness to participate in this study. Following informed consent, participants will be asked questions about demographic characteristics (e.g. age, education, employment), medication and psychosocial treatment status, psychiatric symptoms and symptoms severity, and will complete a brief assessment of estimated Intelligence. Those with an Intelligence Quotient (IQ) estimate below 70 or meeting substance dependence criteria at the time of evaluation will be exited from the study. In the same or second assessment session, participants will complete assessments of neuropsychological ability, current functioning, and motivation for treatment. Participants will then be randomly assigned to one of two treatment conditions named "Brain Basics" or "Brain Exercises".

Each treatment condition is structured in a group format of up to 5 participants. Both treatments use commercially available computer-based training software to exercise cognitive skills such as speed of processing, attention, working memory, and verbal memory. Both conditions will entail 50 minutes on the computer and 10 minutes group discussion. In the discussion, participants review the cognitive activities they are working on and how they will help them achieve their recovery goals. The treatment phase will consist of 30 separate sessions each 60 minutes in duration, administered 3 times a week over the course of a 10-week period. Participants will be re-tested on outcome measures approximately 1 week following end of treatment, and again 3 months later.

Typ studiów

Interwencyjne

Zapisy (Rzeczywisty)

122

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • New York
      • Bronx, New York, Stany Zjednoczone, 10467
        • FEGS Bronx Mental Health Clinic
      • Brooklyn, New York, Stany Zjednoczone, 11206
        • Williamsburg Clinic
      • Brooklyn, New York, Stany Zjednoczone, 11207
        • Institute for Community Living
      • New York, New York, Stany Zjednoczone, 10032
        • Nyspi/ Cumc
      • New York, New York, Stany Zjednoczone, 10040
        • The Bridge Inc

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat do 65 lat (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Nie

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  1. Diagnostic and Statistical Manual-IV (DSM-IV) diagnosis of schizophrenia or schizoaffective disorder
  2. Age 18 to 65
  3. English speaking
  4. Psychiatrically stable, verified by current living/treatment status

Exclusion Criteria:

  1. Indication of mental retardation, determined by estimated IQ of less than 70
  2. Hearing or visual impairment that precludes completing assessments
  3. Neurologic illness that may affect brain physiology (e.g. Parkinson's, seizure disorder, epilepsy)
  4. Current substance dependence symptoms in the past 6 weeks
  5. Participation in cognitive remediation in the 12 months prior to study entry.

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Pojedynczy

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Aktywny komparator: Brain Basics for Impaired Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktywny komparator: Brain Basics for Intact Tone Matchers
Cognitive remediation includes sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktywny komparator: Brain Training for Impaired Tone Matcher
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.
Aktywny komparator: Brain Training for Intact Tone Matchers
Cognitive remediation does not include sensory processing training
Cognitive remediation sessions include working on computer based cognitive exercises and participating in a verbal discussion.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Feasibility
Ramy czasowe: Two years
Feasibility of conducting a larger trial will be measured by recruitment, feasibility of enrollment, stratification, blinding and assessment, acceptability of randomization, retention of subjects
Two years

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Change in neurocognition from baseline to treatment end-point
Ramy czasowe: 10 weeks
Change in neurocognition will be measured with the MATRICS Consensus Cognitive Battery, including measures of: a) working memory; b) attention/vigilance; c) verbal learning; d) visual learning; e) processing speed; f) reasoning and problem solving.
10 weeks
Change in neurocognition from baseline to 3-month follow-up
Ramy czasowe: 5.5 to 6 months
Change in neurocognition will be measured with the MATRICS Consensus Cognitive Battery (see above).
5.5 to 6 months

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
Tone Matching Ability - Treatment end-point
Ramy czasowe: 10 weeks
Tone matching (percent correct) will be assessed at baseline and at treatment end-point, using pairs of 100-ms tones in series, with 500-ms inter-tone interval.
10 weeks
UCSD Performance-Based Skills Assessment (UPSA)-Brief - treatment end-point
Ramy czasowe: 10 weeks
The UPSA - Brief is a proxy measure of daily functioning skills. Change from baseline to treatment end-point will be assessed.
10 weeks
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - Treatment end-point
Ramy czasowe: 10 weeks
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to treatment end-point will be assessed.
10 weeks
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR)
Ramy czasowe: 10 weeks
Intrinsic Motivation Inventory for Schizophrenia Research (IMI-SR), a 21 item 7-point Likert type scale designed to assess a participant's subjective experience of an activity, specifically in an experimental setting (e.g. "I enjoyed doing this activity very much"). The IMI-SR will be administered at the first and last treatment sessions.
10 weeks
Perceived Competency Scale (PCS)
Ramy czasowe: 10 weeks
The PCS consists of 4 items on a 7-point Likert-type scale that assess feelings of competency when performing computer-based learning activities, with higher scores indicating greater perceived competency. The PCS will be administered at the first and last treatment sessions.
10 weeks
Tone Matching ability - 3-month follow up
Ramy czasowe: 5.5 to 6 months
Tone Matching (percent correct) will be assessed at baseline and 3-month follow-up, using pairs of 100-ms tones in series, with 500-ms inter-tone interval.
5.5 to 6 months
UCSD Performance-Based Skills Assessment (UPSA)-Brief - 3-month follow-up
Ramy czasowe: 5.5 to 6 months
The UPSA-Brief is a proxy measure for daily functioning skills. Change from baseline to 3-month follow-up will be assessed.
5.5 to 6 months
Structured Clinical Interview for the Positive and Negative Syndrome Scale (SCI-PANSS) - 3-month follow-up
Ramy czasowe: 5.5 to 6 months
The SCI-PANSS is a semi-structured interview containing 30 items that assess symptoms of psychotic disorders including positive, negative and general psychopathology. Change from baseline to 3-month follow-up will be assessed.
5.5 to 6 months

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Śledczy

  • Główny śledczy: Alice Medalia, PhD, NYSPI

Publikacje i pomocne linki

Osoba odpowiedzialna za wprowadzenie informacji o badaniu dobrowolnie udostępnia te publikacje. Mogą one dotyczyć wszystkiego, co jest związane z badaniem.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów

1 września 2013

Zakończenie podstawowe (Rzeczywisty)

2 października 2017

Ukończenie studiów (Rzeczywisty)

20 marca 2019

Daty rejestracji na studia

Pierwszy przesłany

13 września 2013

Pierwszy przesłany, który spełnia kryteria kontroli jakości

13 września 2013

Pierwszy wysłany (Oszacować)

18 września 2013

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

16 września 2020

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

11 września 2020

Ostatnia weryfikacja

1 września 2020

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • #6721
  • 1R34MH100317-01 (Grant/umowa NIH USA)

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Badania kliniczne na Cognitive remediation

Subskrybuj